The FDA’s Anesthetic and Analgesic Drug Products Advisory Committee is scheduled to meet to discuss the safety and efficacy of MoxDuo, a new morphine sulfate and oxycodone hydrochloride combination. Moxduo will be used to treat moderate to severe acute pain where the use of opioid analgesic is appropriate, according to Pain Medicine News. If MoxDuo is approved, it’ll be the first combination drug to include two immediate-release opioids.
Listen to whole story on NPR's Morning Edition here.
SHARE:
Facebook
Twitter
LinkedIn
Email
Do you need Substance Abuse Professional Services?
ASAP has a nationwide reach in all 50 states and U.S. territories. Our trained and knowledgeable team will assist you in understanding the process and signing up. It’s fast and easy to enroll with ASAP! 888.792.2727 x607
888-792-2727